Scouting report · OPCH

John C. Rademacher

Ran Option Care before its 2019 BioScrip merger; CEO of the combined company since

Born / age
(59)
Role
President & Chief Executive Officer; director
In the role
7 yr
Education
BA Hillsdale College
Front Office rank
not ranked yet
OPCH
Option Care Health, Inc.Healthcare services
Title
President & Chief Executive Officer; directorsrc
In role
since 2019-08 (7 yr)
Stake value—no holding or price on file
—thin record

Scouting sheetas of 25 Sep 2026

Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design6588% performance-conditioned · ebitda, revenue, individual, eps, time only · 97.1% for · 4.46% of net income
Skin in the game—no holding or price on file
—Hit rate
88%Pay at risk
97%Say-on-pay
—Airtime on calls
Beat
0
Met
0
Missed
0
Withdrawn
0
Still open
0
Answers on calls
0
Questions dodged
0
Dodges / 100 answers
—

Personal and ownership data

Full name
John C. Rademacher
Age
59src
Education
BA Accounting, Hillsdale Collegesrc

Not on file yet: born, place of birth, citizenship, marital status.

Shares held
1,102,478 OPCH, 2026-03-15src
Share of company
0.7%
Traded, 12 months
bought $265k, sold $0src
Last pay
$9.3m 2025src
Pay at risk
88%
Say-on-pay vote
97.1% forsrc
CEO pay ratio
167 : 1

What to weigh

Watch 5

  • FY2026 revenue guidance of $5.8-6.0bn, issued 2026-02-24, was cut to $5.675-5.775bn on 2026-04-30. Q1 revenue grew 1.3% and adjusted EBITDA fell 6.3%, and he said the company was not satisfied with its revenue growthsrc
  • On 2026-07-29 the adjusted EBITDA range was narrowed to $480-495m (top end down from $505m) while the revenue range was held; Q2 revenue grew 1.9%src
  • Only 50.6% of votes backed say-on-pay in 2024. The company blamed one-time supplemental equity grants and cash awards tied to the terminated Amedisys deal in 2023, the year his reported pay was $16.6m including $5.1m of optionssrc
  • PSUs pay 75% on three-year adjusted EPS and 25% on revenue and adjusted EBITDA growth; the targets are not disclosed. His bonus target rose from 130% to 150% of salary in 2025src
  • Senior team turnover: CFO Michael Shapiro handed over to Meenal Sethna on 2025-10-01 and the Chief Growth Officer left on 2026-05-08src

In their favour 2

  • Open-market purchase of about $265k in May 2026. No open-market sales in the last 12 months; the only disposals were shares withheld for taxsrc
  • Policy bans hedging and pledging; CEO ownership guideline is 5x salary, and the proxy says every NEO complied or was on track at 2025 year endsrc

Pay

Salary and otherBonus, stock, options, incentive

  • $16.6m2023
  • $8.2m2024
  • $9.3m2025
The table
YearSalaryBonusStockOptionsIncentiveOtherTotal
2023$1.0m$0$7.9m$5.1m$2.6m$13k$16.6msrc
2024$1.0m$0$6.0m$0$1.2m$14k$8.2msrc
2025$1.0m$0$6.5m$0$1.7m$101k$9.3msrc
Bonus pays on
MIP target 150% of salary behind an Incentive EBITDA funding gate ($444.15m): 50% adjusted EBITDA (target $465m, actual $471.3m), 30% revenue (target $5,334m, actual $5,649.5m), 20% individual; formula paid 110% of target, his award $1.665m
Long-term award pays on
$6.5m target: 60% PSUs (three-year cumulative adjusted EPS 75%, average revenue and adjusted EBITDA growth 25%; 0-200%, targets undisclosed) and 40% RSUs vesting a third a yearsrc
  • Pay at risk 88% performance-conditioned
  • Pays on returns ebitda, revenue, individual, eps, time only
  • Shareholder vote 97.1% for
  • Pay vs profit 4.46% of net income

CEO pay ratio 167 : 1

Career

  1. 2019 – now
    Option Care Health (listed; formerly BioScrip)src
    President & CEO; director
    Appointed 2019-08-06 on completion of the Option Care / BioScrip merger
  2. 2017 – 2019
    Option Care (private)src
    Chief Executive Officer (interim at first); director from 2018
    DEFM14A-2019 says CEO since August 2017; DEF14A-2026 lists 'President and CEO, 2018-present' and 'COO 2015-2018'
  3. 2015 – 2017
    Option Care (private)src
    Chief Operating Officer
  4. 2012 – 2014
    Cardinal Healthsrc
    President and General Manager, Ambulatory Care
  5. 2007 – 2012
    Cardinal Healthsrc
    President and General Manager, Nuclear & Pharmacy Services
  6. 2001 – 2007
    CIGNAsrc
    Executive roles incl. President of CareAllies, LLC and COO of CIGNA Behavioral Health business units

Undated in the sources

  • Deloitte Consultingsrc, Strategy consultant

Not located: 2014-2015 between Cardinal Health and Option Care not described in any source read; years at Deloitte Consulting not stated

The promise ledger

No promise on the record yet: the research routine has not scored this company's guidance.

Background

  • Family The 2026 proxy states there are no family relationships among the executive officers and directorssrc
  • Boards Director of Thrivent Financial for Lutherans, a privately held financial services company; no other public-company boardsrc
  • Other Holds an employment agreement signed before the 2019 merger (confidentiality, non-solicit, non-compete). In February 2024 he gave up its severance terms and moved to the Executive Severance Plansrc
  • Other Recommends pay for the other named executives; his own pay is set by the independent directors without him presentsrc

Sources12